Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SPHK2 | Q9NRA0 | 11/20 | 0.48 |
| ▸ | SPHK1 | Q9NYA1 | 9/20 | 0.48 |
| ▸ | LPL | P06858 | 3/20 | 0.43 |
| ▸ | LIPG | Q9Y5X9 | 3/20 | 0.43 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4400096 | 0.82 | KDM4E (0.46) | SPHK2SPHK1HSD11B1 | |
| SCHEMBL4401356 | 0.79 | RAB9A (0.47) | SPHK2SPHK1HSD11B1L3MBTL1 | |
| SCHEMBL9658657 | 0.78 | LPL (0.59) | LPLLIPGHSD11B1TDP1L3MBTL1 | |
| SCHEMBL4069019 | 0.76 | SPHK2 (0.47) | SPHK2SPHK1LPLLIPGTDP1 | |
| SCHEMBL28079356 | 0.76 | LPL (0.61) | LPLLIPGTDP1L3MBTL1 | |
| SCHEMBL94884 | 0.74 | SPHK2 (0.56) | SPHK2SPHK1LPLLIPG | |
| SCHEMBL94883 | 0.74 | SPHK2 (0.54) | SPHK2SPHK1LPLLIPG | |
| SCHEMBL6059834 | 0.73 | LPL (0.54) | LPLLIPGHSD11B1 | |
| SCHEMBL3790301 | 0.72 | SPHK2 (0.50) | SPHK2SPHK1LPLLIPGTDP1 | |
| SCHEMBL199210 | 0.72 | LPL (0.52) | LPLLIPGHSD11B1TDP1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2043644-A1 | NF- B INHIBITOR | Otsuka Pharmaceutical Co., Ltd. (JP) | 2009-04-08 | — | — | EP | disclosed |
| WO-2008010601-A1 | NF- ϰB INHIBITOR | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2008-01-24 | — | — | WO | disclosed |